Dr Julian Kenyon has published two papers in the area of the microbiome, which have been published in the Human Microbiome Journal.
A Retrospective Outcome Study of 42 Patients with Chronic Fatigue Syndrome, 30 of Whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation.
The gut microbiome comprises the community of microorganisms in the intestinal tract. Research suggests that an altered microbiome may play a role in a wide range of disorders including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
42 participants with ME/ CFS with Irritable Bowel Syndrome (IBS) were allocated into one of two groups, 21 were treated with standard oral approaches, which centred around various nutritional remedies, probiotics, prebiotics, dietary advice and lifestyle advice. The second group who had mostly failed using oral approaches, were treated with Faecal Microbiome Transplantation (FMT). Each patient received 10 Implants, each from a different screened donor, and the Implants were processed under anaerobic conditions.
Potential clinical usefulness of gut microbiome testing in a variety of clinical conditions
The gut microbiome comprises the community of microorganisms in the intestinal tract. Over the last five years, interest in the gut microbiome has grown considerably driven by new techniques in DNA sequencing allowing for characterisation of gut bacteria and the recognition of the potential impact the microbiome may have on health.